News | October 18, 2024
MedGenome completes 10 years in genomics in India
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
The acquisition will strengthen the overall company’s position as leading global CRO services partner
He holds a Master’s in Management from the National University of Singapore
India has taken the lead in recognising NAFLD as a major non-communicable disease
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Subscribe To Our Newsletter & Stay Updated
